New monthly shot could stop COVID-19 before it starts
Prevention
Ongoing
This study tests a new drug called VYD2311, a monoclonal antibody that blocks the COVID-19 virus from entering cells. About 1,770 adults and teens aged 12 and older receive either VYD2311 or a placebo as a monthly shot for 3 months. The goal is to see if it safely prevents COVID-…
Phase: PHASE3 • Sponsor: Invivyd, Inc. • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC